US 7317022
Benzoimidazolone-carboxamide compounds as 5-HT4 receptors agonists
granted A61KA61K31/46A61K31/496
Quick answer
US patent 7317022 (Benzoimidazolone-carboxamide compounds as 5-HT4 receptors agonists) held by Theravance, Inc. expires Mon Jan 03 2028 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Theravance, Inc.
- Grant date
- Tue Jan 08 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 03 2028 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 15
- CPC classes
- A61K, A61K31/46, A61K31/496, A61P, A61P1/00